Blog - Page 853 of 5707 - QualityStocks

TuesdayNov 08, 2022 9:45 am

Rising Investment In Clean Energy Drives Optimism for Correlate Infrastructure Partners Inc. (CIPI)

Nearly a decade has passed since the Paris Accords established international cooperation on curbing fossil fuel pollutants believed to be responsible for adversely affecting the earth’s climate, and some agencies worry that not enough is happening to meet the accords’ goals Despite concerns about obstacles to renewable energy adoption, the same agencies note that investment in climate-friendly technologies is rising Correlate Infrastructure Partners is a U.S.-based company works with the commercial real estate industry to drive the transition to climate-friendly energy sources, helping clients analyze their utilities use, identifying ways to improve their ESG outcomes, and presenting funding opportunities to…

TuesdayNov 08, 2022 9:00 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Set to Benefit from Increased Government Focus on Online Privacy

The U.S. Federal Trade Commission is increasingly seeking to protect the online privacy rights of consumers The FTC recently sued data broker Kochava for brokering the geolocation details of millions of consumers Texas Attorney General Ken Paxton has filed suit against Google for allegedly collecting customer information without consent Reklaim enables users to reclaim their data – providing the option to delete it or monetize it A poll conducted during the summer of 2021 showed that 13 percent of UK teens and 6 percent of American teens linked Instagram usage to suicidal thoughts. Even more surprising is the fact that…

MondayNov 07, 2022 1:49 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Targeted ‘Finish Line Is Within Sight’ as It Pursues Potential GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail in glioblastoma (“GBM”) treatment. The interim analysis data from this potentially pivotal trial is expected in mid-2023… Berubicin was the first [anthracycline] to provide scientific data which appears to demonstrate its ability to cross the blood-brain barrier and was designed with a molecular target of topoisomerase II enzymes responsible for cleaving and recombing double-stranded DNA during cellular replication,” a recent article explains. “Since the beginning…

MondayNov 07, 2022 1:30 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd.’s (CSE: HEAT) (OTCQB: HLRTF) Enhanced Solution Holds Potential to Simplify, Redefine EV Charging

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a company developing transformative power conversion technologies, has sought to introduce its proprietary solution into the global vehicle-to-grid technology space. “Hillcrest Energy Technologies has filed a patent for an enhanced powertrain solution, which offers the potential to simplify EV charging and redefine how the industry envisions charging infrastructure. The company believes the most exciting benefits of the enhanced powertrain solution are the ability to eliminate the onboard charger and booster from an EV, as well as faster, anywhere charging including direct DC, wireless and bidirectional charging across current and future power levels,” a recent article…

MondayNov 07, 2022 12:08 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2022 Results, Continued Strengthening of Leading Position in Uranium, Rare Earth Elements

Energy Fuels (NYSE American: UUUU) (TSX: EFR) announced its financial results for the quarter ended Sept. 30, 2022. Among the highlights, the company reported a robust balance sheet with $122.3 million of working capital as of Sept. 30, 2022, including $77.1 million of cash and cash equivalents, $11.6 million of marketable securities, $27.3 million of inventory, and no short-term (or long-term) debt. The company’s product inventory has a value of $44.1 million at current commodity prices. “Energy Fuels continues to strengthen our U.S. market leading position in uranium and rare earth elements, which are both critical to the clean energy…

MondayNov 07, 2022 12:00 pm

GeoSolar Technologies Inc. Reimagining the Suburbs as Environmentally Green

2021 represented the first time in half a century that large urban counties experienced negative growth Migration to suburbs and exurban counties contribute more to carbon emissions, highlighting the need for a transition to renewable energy to combat climate change GeoSolar Technologies is an emerging leader with its whole-home system using solar, geothermal, and proprietary air filtration technologies Americans in 2021 exited urban counties in droves, heading for suburban and exurban counties at a record pace. From an environmental perspective, the transition can have unintended negative consequences, as people generally have more property outside the city, drive more, and use…

MondayNov 07, 2022 11:41 am

QualityStocksNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Partner with Leading Entities to Complete Project Resulting in Enhanced Road Safety

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, has joined with two other leading companies to complete a proof-of-concept project confirming that an integrated system has the ability to warn drivers of unseen hazards ahead. The other two companies involved in the project, dubbed Periscope, are ALP.Lab GmbH, an Austria-based technology provider of autonomous vehicle testing solutions, and TE Connectivity, a world leader in sensors and connectors. According to the announcement, Periscope relies on lidar sensors strategically located at intersections to extend a driver’s field of view and alert them about a pedestrian approximately five seconds…

MondayNov 07, 2022 11:15 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Assisting EV Manufacturers in Reducing Costs; Company Announces Appointment of Samuel Yik as CFO

The manufacture of lower cost electric vehicles is conditional on the decrease of component costs, with battery packs forming one of the largest parts of their cost structure Hillcrest Energy Technologies’ revolutionary inverter technology, which forms an integral part of an electrical vehicle’s powertrain, allows EV’s to improve thermal management and reduce switching losses Improved power quality resulting from more efficient power inverters can enable automakers to obtain higher powertrain efficiency and consequently, reduce their battery packs Hillcrest Energy Technologies separately seized the opportunity to announce the appointment of Samuel Yik as their new CFO One of the world’s most…

MondayNov 07, 2022 11:12 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Featured in Cleantech and Climate Change Podcast

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in a new edition of the Cleantech and Climate Change Podcast issued by Investorideas.com, a global news source and leading investor resource covering clean technology and renewable energy stocks issues. Mullen’s Founder, Chairman and CEO David Michery joined the podcast to discuss recent news and milestones and lay out Mullen’s future plans for manufacturing and sales. During the interview, Michery goes into detail on the significance of Mullen’s acquisition and controlling interest in EV truck innovator, Bollinger Motors (the company’s first EV acquisition), and the purchase of ELMS…

MondayNov 07, 2022 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Is ‘One to Watch’

BiondVax has an exclusive worldwide license to commercialize NanoAbs for the treatment of COVID-19 The company plans to initiate a Phase 1/2a clinical trial of its inhaled COVID-19 therapeutic NanoAb in 2023 BiondVax has exclusive options for worldwide licenses for NanoAbs to treat other disorders with large, underserved needs The company has filed a Registration Statement with the SEC for an underwritten offering of shares BiondVax Pharmaceuticals (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. In collaboration with the prestigious Max Planck Institute…

Site Search

Company Search